Home/Filings/4/0001209191-11-058045
4//SEC Filing

Belle Gerald P. 4

Accession 0001209191-11-058045

CIK 0001459450other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:07 PM ET

Size

6.9 KB

Accession

0001209191-11-058045

Insider Transaction Report

Form 4
Period: 2011-11-22
Transactions
  • Purchase

    Common Stock

    2011-11-23$2.48/sh+6,100$15,09840,600 total
  • Purchase

    Common Stock

    2011-11-22$2.48/sh+34,200$84,64534,500 total
Footnotes (4)
  • [F1]The shares were purchased in multiple transactions at prices ranging from $2.46 to $2.48 per share. The price reported above is the weighted average purchase price. See footnote (4)
  • [F2]Includes 300 shares acquired on June 30, 2009 in a pro rata distribution by Myriad Genetics, Inc. ("Myriad Genetics") of all of its shares of the Issuer's common stock in connection with the spin-off of the Issuer by Myriad Genetics.
  • [F3]The shares were purchased in multiple transactions at prices ranging from $2.46 to $2.48 per share. The price reported above is the weighted average purchase price. See footnote (4)
  • [F4]The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth above.

Issuer

Myrexis, Inc.

CIK 0001459450

Entity typeother

Related Parties

1
  • filerCIK 0001416041

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:07 PM ET
Size
6.9 KB